24 Participants Needed

TMS + Language Therapy for Aphasia

(TMS Trial)

HD
DS
Overseen ByDaniela Sacchetti, MS
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether combining Transcranial Magnetic Stimulation (TMS) with Speech-Language Therapy (SLT) can improve speech and understanding in people with mild aphasia, a language disorder caused by a stroke. Researchers aim to determine if this combination is more effective than a placebo version of TMS, which mimics TMS but has no real effect. The trial seeks participants who had a stroke on the left side of their brain over six months ago, have mild aphasia, and can speak English. Participants will undergo 10 treatment sessions and follow-up assessments to evaluate progress. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important early findings.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that Transcranial Magnetic Stimulation combined with Speech-Language Therapy is safe for treating mild aphasia?

Research has shown that Transcranial Magnetic Stimulation (TMS) is generally safe for people. Studies have found that most patients tolerate TMS well when treating conditions like post-stroke aphasia, which involves difficulty with language after a stroke. One study found that TMS safely improved speech, particularly in understanding spoken words.

Another study demonstrated that TMS, when combined with intensive therapy, remained safe and practical, even during longer sessions. Common side effects include mild headaches or discomfort at the stimulation site, but serious side effects are rare.

Since TMS is already used for other conditions, such as depression, this further suggests its safety. Overall, TMS appears promising as a safe method for aiding language recovery after a stroke.12345

Why do researchers think this study treatment might be promising for aphasia?

Researchers are excited about using Transcranial Magnetic Stimulation (TMS) for treating aphasia because it offers a non-invasive approach that directly targets brain activity. Unlike traditional speech therapy, which primarily focuses on exercises to improve language skills, TMS uses magnetic fields to stimulate nerve cells in the brain regions responsible for language. This method has the potential to enhance the effectiveness of speech-language therapy by directly influencing brain function, potentially leading to faster and more significant improvements in language abilities.

What evidence suggests that TMS combined with SLT might be an effective treatment for mild aphasia?

In this trial, participants will be randomized into two groups to evaluate the effectiveness of Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) for aphasia. Research has shown that using TMS along with SLT can aid individuals with aphasia, a language problem caused by brain damage. For those who experienced a stroke at least six months ago, TMS significantly improved language skills. One study found that TMS had both immediate and long-lasting positive effects on language recovery. Another study showed that low-frequency TMS, when used with SLT, improved language abilities in stroke patients with long-term aphasia. These findings suggest that TMS, combined with SLT, could effectively enhance speech and understanding in people with mild aphasia after a stroke.23678

Who Is on the Research Team?

HB

H. Branch Coslett, MD

Principal Investigator

University of Pennsylvania

Are You a Good Fit for This Trial?

This trial is for individuals with mild aphasia due to chronic stroke. Participants must complete a medical screening, be eligible based on their MRI results, and commit to 10 consecutive sessions of treatment along with follow-up assessments.

Inclusion Criteria

My stroke happened over 6 months ago.
I had a stroke affecting the left side of my brain.
Mild Aphasia (WAB AQ score > 85)
See 1 more

Exclusion Criteria

I have been diagnosed with tinnitus.
Ongoing substance or alcohol abuse
Active psychiatric disorders (e.g., bipolar disorder, schizophrenia)
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Baseline Assessment

Participants undergo a battery of tests to define their language function and a research MRI scan

1 week
1 visit (in-person)

Treatment

Participants receive 10 consecutive sessions of TMS and SLT treatment over 2 weeks

2 weeks
10 visits (in-person)

Follow-up

Participants complete follow-up assessments to monitor language functioning

4 months
3 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Speech-Language Therapy
  • Transcranial Magnetic Stimulation
Trial Overview The study tests if Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) can improve speech and comprehension in people with mild aphasia from stroke. It compares real TMS against sham TMS over two weeks of daily sessions.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Real TMSExperimental Treatment2 Interventions
Group II: Fake TMSPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Temple University

Collaborator

Trials
321
Recruited
89,100+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Published Research Related to This Trial

Repetitive transcranial magnetic stimulation (rTMS) has been shown to be more effective than sham rTMS and conventional rehabilitation for improving language recovery in stroke patients with aphasia, based on a meta-analysis of 28 studies involving 1287 patients.
Low-frequency rTMS specifically demonstrated greater improvements in language recovery, particularly in naming and comprehension, while high-frequency rTMS did not show significant benefits compared to sham or conventional treatments.
Effects of repetitive transcranial magnetic stimulation (rTMS) on aphasia in stroke patients: A systematic review and meta-analysis.Zhang, J., Zhong, D., Xiao, X., et al.[2022]
The combination of 6-Hz-primed low-frequency rTMS and intensive speech therapy was safely administered to four post-stroke patients without any adverse effects during an 11-day treatment period.
All patients showed significant improvements in language function, indicating that this treatment protocol may be an effective option for enhancing recovery in individuals with post-stroke aphasia.
Therapeutic application of 6-Hz-primed low-frequency rTMS combined with intensive speech therapy for post-stroke aphasia.Kakuda, W., Abo, M., Momosaki, R., et al.[2016]
In a study involving 24 post-stroke patients with aphasia, combining low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) with intensive speech therapy (ST) led to significant improvements in language abilities, particularly for nonfluent aphasic patients who showed enhanced auditory comprehension, reading comprehension, and repetition.
The targeted application of LF-rTMS based on fMRI findings suggests a tailored approach to treatment, with nonfluent patients benefiting from stimulation of the inferior frontal gyrus and fluent patients from stimulation of the superior temporal gyrus, indicating the potential of this method as a neurorehabilitative protocol.
Effectiveness of low-frequency rTMS and intensive speech therapy in poststroke patients with aphasia: a pilot study based on evaluation by fMRI in relation to type of aphasia.Abo, M., Kakuda, W., Watanabe, M., et al.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39999397/
Transcranial Magnetic Stimulation Combined With ...This study provides Class III evidence that in patients with aphasia 6 or more months after a stroke, 1-Hz rTMS combined with intensive M-MAT improves WAB-AQ ...
Long-Term Therapy With Transcranial Magnetic ...Findings In this randomized clinical trial, which included 63 participants diagnosed with PPA, TMS administered over a 6-month period mitigated ...
The Therapeutic Effect of Transcranial Magnetic ...The results showed that TMS treatment has significant immediate (Hedges' g=0.37) and maintenance (Hedges' g=0.34) effects on post-stroke aphasia. Additionally, ...
Transcranial Magnetic Stimulation Combined With ...This study provides Class III evidence that in patients with aphasia 6 or more months after a stroke, 1-Hz rTMS combined with intensive M-MAT improves WAB-AQ ...
Systematic Review and Meta-Analysis of Its Effect Upon ...The subgroup analyses of language performance showed positive effects of LF-rTMS among stroke patients with chronic aphasia and acute aphasia. LF-rTMS + SLT had ...
Transcranial Magnetic Stimulation and Aphasia RehabilitationGiven the extensive safety data and the strict adherence of our study protocol to current safety guidelines and recommendations endorsed by the ...
Efficacy and safety of repetitive transcranial magnetic ...This study shows that rTMS can safely and effectively improve speech function in patients with post-stroke aphasia (PSA), particularly in auditory comprehension ...
Effect of High Frequency Transcranial Magnetic Stimulation ...Excitatory rTMS protocol appeared to be a safe modality, thus it should be further tested in blinded studies on larger sample size assessing its safety and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity